I

Inhibrx
D

INBX

14.640
USD
0.05
(0.34%)
مغلق
حجم التداول
973
الربح لكل سهم
0
العائد الربحي
0
P/E
0
حجم السوق
227,271,693
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Inhibrx Biosciences Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.